Pushing through barriers to commercial launch success, with Amanjeet Singh Saluja
Despite billions spent on new technology and improving data analytics, companies continue to struggle with commercial launch success, with around 35% of launches missing expectations since 2012.
Why is launch underperformance such a big problem, and why isn’t technology alone offering a sufficient solution? In a special episode of the pharmaphorum podcast, sponsored by Axtria, we spoke with Amanjeet Singh Saluja, a Principal at Axtria, about the current state of affairs in launch success.
In our conversation, Singh Saluja digs into the strategic and institutional causes of failed launches and what strategies can help redeem them. He also discusses some of the external forces that have reshaped the pharma commercialisation industry, and how to keep pace with those trends and changes.
Finally, of course, we talk about agentic AI. Even though it may not be a silver bullet, when used correctly, in the right strategic context, it can make a big difference.
Meet Singh Saluja and other senior life sciences commercialisation leaders at Axtria Ignite 2026, an invitation-only event where the industry works through these challenges and more. June 10-11th in Princeton, NJ. Register here.
You can listen to episode 255 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
About the Interviewee
Amanjeet Singh Saluja is a seasoned leader in AI, analytics, and cloud software. He currently heads a Strategic Business Unit at Axtria Inc., a leading global provider of AI and cloud solutions to the life sciences industry. Singh Saluja has built, scaled, and exited three successful ventures, and is the original inventor of a US patent for collection cycle optimisation through advanced analytics. He brings 26 years of experience advising Fortune 500 clients in financial services, life sciences, and MedTech on risk management, commercial strategies, and artificial intelligence. He has been recognised in Marquis Who’s Who in 2025.
Singh Saluja is particularly skilled at driving growth, improving sales efficiency, optimising costs, cultivating high-performing teams, and fostering a culture of collaboration and excellence through executive leadership. He began his career in process re-engineering and strategy roles at KPMG and Andersen. Singh Saluja holds a degree from the Indian Institute of Technology Kharagpur and an MBA from the Indian Institute of Management, Ahmedabad. He is passionate about leveraging AI and analytics to drive business success.
About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.
